A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Table 2 Synthetic Peptides, second vaccination and immunomonitoring

ID	Amino acid sequence	HLA-restriction	Source protein, HLA-restriction	AA position within source protein
CMV-VPAP	VTEHDTLLY	HLA-A*01	Human cytomegalovirus, DNA polymerase processivity factor (hCMV, VPAP)	245–253
CMV-pp65	YSEHPTFTSQY	HLA-A*01	Human cytomegalovirus, 65 kDa phosphoprotein (hCMV, pp65)	363–373
CMV-VIE1	ELRRKMMYM	HLA-B*08	Human cytomegalovirus, 55 kDa immediate-early protein 1 (hCMV, VIE1)	199–207
EBV-GP350	PRPVSRFLGNNSILY	HLA-DR	Epstein-Barr virus, Envelope Glycoprotein GP350 (EBV, gp350)	268–282
CMV-pp65^283–299	KPGKISHIMLDVAFTSH	HLA-DR	Human cytomegalovirus, 65 kDa phosphoprotein (hCMV, pp65)	283–299
CMV-pp65^510–524	YQEFFWDANDIYRIF	HLA-DR	Human cytomegalovirus, 65 kDa phosphoprotein (hCMV, pp65)	510–524